The blood banking devices market is estimated to be valued at USD 25.28 Bn in 2025 and is expected to reach USD 40.34 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.
The blood banking devices market is witnessing positive trends with the rising prevalence of blood disorders and chronic illnesses, increasing trauma and surgical procedures, greater public awareness, and enhanced blood donation initiatives such as mobile camps and digital tracking systems.
However, high capital investment and maintenance costs associated with blood banking devices pose a significant challenge for the growth of the global blood banking devices market. Setting up a blood bank requires huge upfront capital for purchasing expensive tools and equipment necessary for collecting, testing, processing, storing, and distributing blood and blood components.
|
Current Events |
Description and its impact |
|
Geopolitical & Market Pressures |
|
|
Public Health Emergencies |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The escalating prevalence of chronic diseases requiring regular blood transfusions represents a fundamental driver reshaping the global blood banking devices market landscape. Conditions such as sickle cell disease, thalassemia, chronic kidney disease, and various hematological malignancies necessitate frequent blood component transfusions, creating sustained demand for sophisticated blood banking infrastructure.
For instance, June 14 marks World Blood Donor Day, a global initiative to raise awareness about the critical importance of safe blood and the role voluntary blood donors play in saving lives. Every donor who gives the gift of life is honored at Oxymed Hospital Chennai.
The shortage of voluntary blood donors has been a major challenge restraining the growth of the global blood banking devices market. An insufficient blood donor population has made it difficult for blood banking organizations to meet the ever-growing demand for blood and blood products. Relying on a pool of voluntary unpaid donors allows for a safe and sustainable collection of blood.
In terms of product type, the blood collection devices segment is estimated to contribute the highest market share with 35.0% in 2025.
Blood collection devices–including vacuum tubes, needles/syringes, lancets, micro-containers, and automated collection systems–constitute a pivotal segment of the blood banking market, projected to grow. Emerging innovation focuses on automation, safety, and patient comfort: automated venipuncture systems guided by AI and ultrasound, safety-engineered needles that reduce needlestick incidents, and minimally invasive capillary devices aimed at point-of-care and home use.
The integration of AI technologies is enhancing the efficiency, accuracy, and reliability of blood banking processes, with companies leveraging AI to address critical challenges such as donor screening, blood storage, and compatibility testing. This growing adoption of AI is reshaping the landscape by optimizing operations and improving patient outcomes.
To learn more about this report, Download Free Sample
North America is the largest market for blood banking devices, with an estimated market share of 42.0% in 2025, as the region has witnessed increased demand for blood collection supplies to support its growing population in need of blood transfusions and testing. Hospitals and blood banks in the U.S. require reliable access to quality collection supplies to protect patients and staff from exposure risks.
As per the American Blood Centers, over 100 leading organizations from across the nation united to kick off Blood Advocacy Week 2025, calling on members of congress to take decisive action in supporting the blood supply as a national priority. Blood advocacy week, an annual initiative led by America’s Blood Centers, unites stakeholders to advocate for policies that highlight the importance of blood for patients, communities, and the healthcare system.
Asia Pacific is the second largest market for blood banking devices, with an estimated share of 28% in 2025. Several factors have contributed to the leadership position of blood banking devices in Asia Pacific. The blood processing devices sub segment contributes the highest share in the Asia Pacific blood banking devices market. This is due to the growing volume of blood collection in major APAC countries such as China, India, and Japan which process large amounts of blood annually.
For instance, as per a report published by the World Health Organization (WHO) in May 2025, an increase of 10.7 million blood donations from voluntary unpaid donors from 2008 to 2018 has been reported by 119 countries. The maximum increase in absolute numbers was reported in the Western Pacific Region (4.15 million donations), followed by South-East Asia (3.05 million).
The U.S. healthcare system is gravitating toward automation, efficiency, and safety in blood collection. Hospitals are adopting automated venipuncture systems to reduce human error and speed up sample collection—some even integrate with Electronic Health Records (EHR) for real-time tracking.
According to Red Cross Blood Donation, 13.6 million units of whole blood and red blood cells are collected in the U.S. in a year. Each new donor helps us meet patient needs.
Similarly, according to the Pan American Health Organization (PAHO), in 2023, 56.8% of donated blood came from voluntary donors—a 6.7% increase compared to 2019—resuming the pre-pandemic growth trend. This progress was driven by digital campaigns, mobile drives, and institutional partnerships.
China’s rapid expansion of its healthcare infrastructure—especially in tertiary hospitals—is driving greater demand for vacuum blood collection devices. A push for higher diagnostic accuracy, quicker turnaround, and streamlined workflows fuels investment in safety-engineered systems.
India is upgrading blood safety via expanded deployment of advanced testing and blood collection infrastructure. The DCGI has approved nucleic acid testing (NAT) for imported blood products—enhancing safety by detecting low-level HIV, HBV, and HCV infections.
Germany’s focus lies in precision diagnostics and regulatory compliance, influencing the country's blood collection device ecosystem. Innovative capillary blood testing methods—using finger‑prick samples paired with smartphone analysis—are being piloted for colorectal cancer screening, offering a boost to point-of-care options and decentralized sampling.
The Blood Banking Devices Market faces several unmet needs identified by Key Opinion Leaders (KOLs), which impact operational efficiency, accessibility, and safety. These gaps stem from technological limitations, regulatory hurdles, and infrastructural challenges.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 25.28 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.9% | 2032 Value Projection: | USD 40.34 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Haemonetics Corporation, Fresenius Kabi, Terumo BCT, Inc., Immucor, Macopharma, B. Braun, Grifols, Beckman Coulter, and Sarstedt. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: The blood banking devices market encompasses a range of medical equipment and technologies specifically designed for the collection, processing, storage, and transfusion of blood and its components. This market includes devices such as blood collection tubes, needles, syringes, blood bags, centrifuges, blood storage refrigerators, and blood typing analyzers. These tools are essential in hospitals, diagnostic laboratories, blood banks, and research institutions to ensure the safe and efficient management of blood supplies for diagnostic testing, therapeutic treatments, and emergency care.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
